Scientists identify KRAS rearrangements in metastatic prostate cancer
Scientists have uncovered a genetic characteristic of metastatic prostate cancer that defines a rare sub-type of this disease. These findings are published in Cancer Discovery, the newest journal of the American Association for Cancer Research, which will debut at the AACR 102nd Annual Meeting 2011, held April 2-6. Arul M. Chinnaiyan, M.D., Ph.D., an investigator of the Howard Hughes Medical Institute and director of the Michigan Center for Translational Pathology, and colleagues identified an oncogenic gene fusion of KRAS, one of the most studied and well-known oncogenes in a metastatic prostate cancer cell line.
Like most metastatic disease, metastatic prostate cancer has a grim prognosis. As scientists learn more about the genetic characteristics of this disease, they may be able to work backward and accurately predict which early-stage prostate cancers will be more aggressive and thus require additional therapy and management.
"Right now, we can identify the presence of prostate cancer but not accurately predict which of these cancers will have a poor prognosis," said Chinnaiyan. "Although prostate cancer is a leading cause of cancer-related death, we need better prognostic information to separate the slow growing tumors from the more aggressive ones."
Chinnaiyan compared the identification of the KRAS gene in metastatic prostate cancer to the work that has been previously done in breast cancer, where scientists now recognize that breast cancer comes in multiple subtypes and requires different treatment strategies.
"The more we know about the disease biologically, the better we'll be able to treat it," said Chinnaiyan.
Currently, there are no treatments that block the KRAS oncogene, but several are under development that target components of the KRAS signaling pathway.
Source: American Association for Cancer Research
Articles on the same topic
- New prostate cancer test gives more accurate diagnosisWed, 6 Apr 2011, 17:08:50 UTC
- MicroRNA variations associated with earlier prostate cancer diagnosis in African-American men Mon, 4 Apr 2011, 13:34:32 UTC
- New tool allows for an alternate method of prostate cancer diagnosisFri, 1 Apr 2011, 4:34:00 UTC
- Screening does not reduce prostate cancer deathsThu, 31 Mar 2011, 23:05:44 UTC
- Interventional radiologists provide hope in delaying growth, spread of breast cancerTue, 29 Mar 2011, 13:32:40 UTC
- Researchers find many elderly men are undergoing unnecessary PSA screenings Mon, 28 Mar 2011, 21:02:59 UTC
Other sources
- New prostate cancer test gives more accurate diagnosisfrom Science DailyWed, 6 Apr 2011, 19:30:42 UTC
- New prostate cancer test gives more accurate diagnosisfrom PhysorgWed, 6 Apr 2011, 17:30:29 UTC
- MicroRNA variations associated with earlier prostate cancer diagnosis in African-American menfrom Science DailyMon, 4 Apr 2011, 16:33:50 UTC
- MicroRNA variations associated with earlier prostate cancer diagnosis in African-American menfrom PhysorgMon, 4 Apr 2011, 13:31:14 UTC
- Screening does not reduce prostate cancer deathsfrom PhysorgFri, 1 Apr 2011, 8:50:45 UTC
- New tool allows for an alternate method of prostate cancer diagnosisfrom PhysorgFri, 1 Apr 2011, 8:20:53 UTC
- Study: Prostate cancer test doesn't cut death riskfrom AP HealthFri, 1 Apr 2011, 3:30:23 UTC
- Screening does not reduce prostate cancer deaths, study suggestsfrom Science DailyFri, 1 Apr 2011, 1:30:25 UTC
- Prostate cancer test barely alters death riskfrom CBC: HealthThu, 31 Mar 2011, 23:00:46 UTC
- Keeping cancer dormant: Researchers target tumor metabolism by blocking energy production required for malignant cancer growthfrom Science DailyTue, 29 Mar 2011, 15:40:35 UTC
- Interventional radiologists provide hope in delaying growth, spread of breast cancerfrom PhysorgTue, 29 Mar 2011, 13:30:35 UTC
- Many elderly men are undergoing unnecessary PSA screenings, researchers findfrom Science DailyMon, 28 Mar 2011, 21:30:24 UTC
- Researchers find many elderly men are undergoing unnecessary PSA screeningsfrom PhysorgMon, 28 Mar 2011, 21:00:57 UTC